Document Detail

Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study.
MedLine Citation:
PMID:  9368509     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: To evaluate calcium-regulating hormones and parathyroid hormone-related peptide (PTHrP) in normal human pregnancy and postpartum in women not deficient in vitamin D. DESIGN: A prospective longitudinal study was conducted in pregnant Saudi women during the course of pregnancy (n = 40), at term and 6 weeks postpartum (n = 18). Maternal concentrations of serum calcidiol and calcitriol were determined, together with those of serum intact-parathyroid hormone (PTH), PTHrP, calcitonin, osteocalcin, human placental lactogen (hPL), prolactin, vitamin D binding protein, alkaline phosphatase, calcium, phosphate and magnesium. A group of non-pregnant women (n = 280) were included for comparative purposes. RESULTS: The calcidiol concentrations decreased (mean +/- S.D.) significantly from 54 +/- 10 nmol/l in the first trimester to 33 +/- 8 nmol/l in the third trimester (P < 0.001) and remained decreased at term and postpartum (both P < 0.001). The calcitriol concentration increased through pregnancy, from 69 +/- 17 pmol/l in the first trimester to 333 +/- 83 pmol/l at term (P < 0.001). Intact-PTH concentrations increased from 1.31 +/- 0.25 pmol/l in the first trimester to 2.26 +/- 0.39 pmol/l in the second trimester, but then declined to values of the first trimester and increased significantly postpartum (4.02 +/- 0.36 pmol/l) (P < 0.001). PTHrP concentration increased through pregnancy from 0.81 +/- 0.12 pmol/l in the first trimester to 2.01 +/- 0.22 pmol/l at term and continued its increase postpartum (2.63 +/- 0.15 pmol/l) (P < 0.001). Significant positive correlations were evident between PTHrP and alkaline phosphatase up to term (r = 0.051, P < 0.001) and between PTHrP and calcitriol (r = 0.46, P < 0.001), osteocalcin (r = 0.23, P < 0.05) and prolactin (r = 0.41, P < 0.05) during pregnancy. Osteocalcin started to increase from 0.13 +/- 0.01 nmol/l in the second trimester, through pregnancy and postpartum (P < 0.001). Calcitonin was increased more than twofold by the second trimester compared with the first trimester (P < 0.001) and subsequently decreased (P < 0.001). Prolactin concentrations were significantly greater in the second (6724 +/- 1459 pmol/l) and third (8394 +/- 2086 pmol/l) trimesters compared with values before pregnancy (P < 0.001). hPL, increased throughout the course of pregnancy, reaching a maximum at term (7.61 +/- 2.57 microIU/ml). There was no direct correlation between serum calcitriol concentrations during pregnancy and serum prolactin (r = -0.12, P < 0.19) or serum hPL (r = 0.17, P < 0.21). Significant changes were observed in the serum concentrations of calcium and phosphate, but not in that of magnesium, during the course of pregnancy; calcium concentrations showed a maximal decrease at term. CONCLUSIONS: Changes in serum PTHrP during the course of pregnancy, at term and postpartum have been demonstrated, suggesting that the placenta (during pregnancy) and mammary glands (postpartum) are the main sources of PTHrP. No support for the concept of 'physiological hyperparathyroidism' of pregnancy could be demonstrated in the present work. The pregnancy-induced increase in calcitriol concentration may thus be the primary mediator of the changes in maternal calcium metabolism, but the involvement of other factors cannot be excluded.
M S Ardawi; H A Nasrat; H S BA'Aqueel
Related Documents :
9141549 - Inhibin a and activin a in the first trimester of human pregnancy.
19384749 - F(2)-isoprostanes, tocopherols and normal pregnancy.
20482519 - Maternal levels of prostacyclin, thromboxane, icam, and vcam in normal and preeclamptic...
7955459 - Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of down...
19490789 - Leptin in first trimester pregnancy serum: no reduction associated with small-for-gesta...
6872319 - Identification of a factor blocking a cellular cytotoxicity reaction in pregnant serum.
15803959 - Evaluation of dimethoate toxicity on pregnancy in albino mice.
1624019 - Superovulation with human menopausal gonadotropins in the treatment of infertility asso...
7982259 - A cost-benefit analysis of four hormonal contraceptive methods.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of endocrinology / European Federation of Endocrine Societies     Volume:  137     ISSN:  0804-4643     ISO Abbreviation:  Eur. J. Endocrinol.     Publication Date:  1997 Oct 
Date Detail:
Created Date:  1997-12-11     Completed Date:  1997-12-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9423848     Medline TA:  Eur J Endocrinol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  402-9     Citation Subset:  IM    
Department of Clinical Biochemistry, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcifediol / blood
Calcitriol / blood
Calcium / metabolism*
Hormones / blood*
Longitudinal Studies
Osmolar Concentration
Osteocalcin / blood
Parathyroid Hormone-Related Protein
Postpartum Period / blood*
Pregnancy / blood*
Prolactin / blood
Proteins / analysis*
Reference Values
Reg. No./Substance:
0/Hormones; 0/PTHLH protein, human; 0/Parathyroid Hormone-Related Protein; 0/Proteins; 104982-03-8/Osteocalcin; 19356-17-3/Calcifediol; 32222-06-3/Calcitriol; 7440-70-2/Calcium; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High molecular weight forms of IGF-II ('big-IGF-II') released by Wilms' tumor cells.
Next Document:  Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in ...